Billionaire Leon Cooperman Says the Bear Market Is Expected to Continue in 2023 — Here Are 2 ‘Safe Haven’ Stocks That Analysts Like – Yahoo Finance

Feeling optimistic the new year will usher in a change in stock market dynamics and shift sentiment from bear to bull? Well, Leon Cooperman has some bad news for you.
The billionaire investor has been a fully-fledged bear for a while now and 2023 has done little to change his stance. “Anybody looking for a new bull market any time soon is looking the wrong way,” Cooperman said.
In fact, Cooperman thinks there’s only a 5% chance the S&P 500 sees out 2023 above the 4,400 mark (up 13% from current levels), believing the stock market is far likelier to head back down from here.
Cooperman evidently knows a thing or two about investing in bear markets, and if we’re to heed his advice, it’s best to look for ‘safe havens’ to shield from further incoming volatility.
With this in mind, we delved into the TipRanks database and pulled out two stocks that analysts believe offer just that. Moreover, the view on Wall Street is that both are Strong Buys. Let’s see what makes them good shelters from the storm right now.
Ashland Inc. (ASH)
The first stock we’ll look at is American chemicals company Ashland. With a presence in 100+ countries, the company offers additives and specialty ingredients, providing services to clients in a variety of consumer and industrial sectors, such as personal care, automotive, energy, food and beverage, nutraceuticals, pharmaceuticals, and architectural coatings. With a workforce of 3,900, the company has a market cap of $5.77 billion.
And going against the general market trend, Ashland has managed to preserve that market cap over the past year, with the stock seeing out 2022 1% into the green, a far better display than the S&P 500’s losses of 19%.
Delivering strong earnings certainly helps in beating the market, and this is something the company’s most recent report – for the fourth quarter of fiscal year 2022 (September quarter) – managed to pull off. Revenue climbed by 6.8% year-over-year to $631 million, meeting Street expectations while adj. EPS improved by 20% to clock in at $1.46 – 5 cents above the $1.41 consensus estimate. Importantly, the company provided an excellent outlook, with sales for FY23 expected to be in the range between $2.5 billion to $2.7 billion compared to consensus at $2.39 billion.
Laying out the bull-case, BMO analyst John McNulty explains the myriad reasons to back the company.
“ASH’s defensive nature (60-65% of their revenue tied to personal care and life sciences) and its sold out positions in a host of product lines should help to insulate the company from the macro headwinds expected in 2023,” the analyst said. “Further, with ASH increasing its focus on selling products into applications that find /appreciate greater value from ASH’s products (up-selling), they should continue to see positive pricing for the portfolio. Finally, ASH has significant balance sheet strength that affords the company significant flexibility while offering investors financial stability. With all of the above in mind, ASH should provide investors a safe haven in 2023 as macro uncertainty continues.”
Accordingly, McNulty rates ASH shares an Outperform (i.e. Buy), backed by a $139 price target. Investors could be sitting on gains of ~30%, should McNulty’s forecast play out as anticipated. (To watch McNulty’s track record, click here)
Overall, it’s clear that Wall Street agrees with McNulty on the forward prospects for Ashland. The stock’s 8 recent analyst reviews include 7 Buys and 1 Hold, for a Strong Buy consensus indicative of a bullish outlook. The shares are priced at $106.57 and their $131.25 average price target implies a 12-month upside of 23%. (See Ashland stock forecast on TipRanks)
AmerisourceBergen Corporation (ABC)
If recent past performance amidst 2022’s bearish trends is anything to go by, then AmerisourceBergen’s credentials are hard to beat. The American drug wholesale company fared much better than average last year, generating for investors robust returns of 26%.
The company is one of the world’s biggest pharmaceutical service providers, focused both on pharmaceutical manufacturers and healthcare providers, and offering drug distribution and consulting services. In fact, such is its reach, around 20% of all the pharmaceuticals sold and distributed in the U.S. are handled by the company. Additionally, AmerisourceBergen has a strong international presence with more than 150 company-owned offices spread across the globe.
The fact the business is seeing strong demand even against the backdrop of an unfavorable macro was clear to see in the most recently reported statement – for the fourth fiscal quarter of 2022 (September quarter). Revenue came in at $61.17 billion, amounting to a 4% year-over-year increase while adj. EPS clocked in at $2.60. Both results beat Street expectations. For the 2023 outlook, the company called for revenue growth to be in the 5 to 7% range while it reiterated the F2023 adjusted EPS forecast of $11.45 at the midpoint it set at its June investor day.
This stock has picked up interest from J.P. Morgan’s Lisa Gill, who believes the company is set up well to deal with the current market environment.
“We remain positive on ABC given solid FY22 results and FY23 guidance outlook that offers a reasonable view into a challenging environment,” the 5-star analyst explained. “Ultimately, we believe the U.S. Healthcare Solutions business is poised for growth on the back of strong Rx and specialty volumes (including oncology and ophthalmology biosimilars), and should continue to offset FX and inflationary pressures within the International business, which will subside over time… We also believe the company could be a relative safe haven in an uncertain economic environment, as we don’t expect an impact to demand for prescription drugs in an economic downturn.”
These comments underpin Gill’s Overweight (i.e. Buy) rating on ABC shares, while her $191 price target implies one-year share appreciation of ~15%. (To watch Gill’s track record, click here)
Overall, ABC currently has a Strong Buy rating from the analyst consensus, based on 8 analyst reviews, breaking down to 7 Buys and 1 Hold. The shares are priced at $165.71 and have an average price target of $181.63, suggesting a one-year potential upside of ~10%. (See ABC stock forecast on TipRanks)
To find good ideas for stocks trading at attractive valuations, visit TipRanks’ Best Stocks to Buy, a newly launched tool that unites all of TipRanks’ equity insights.
Disclaimer: The opinions expressed in this article are solely those of the featured analyst. The content is intended to be used for informational purposes only. It is very important to do your own analysis before making any investment.
Related Quotes
Time flies. But it also crashes.
Wake up and smell the diesel.
The solar pv sector has been held back by rising costs since the end of 2020, but falling costs in 2023 could spur growth in solar stocks according to a new report from Goldman Sachs
Elon Musk is used to facing critics, haters and detractors. He even likes these battles very much. Sometimes he even tends to provoke his supposed enemies. The Techno King, as he's known at Tesla , likes to turn his opponents' attacks into counterattacks.
The electric-vehicle leader has been hammered by China lockdowns, a possible recession, and CEO Musk’s antics at Twitter. But the company has real strengths and cheap shares.
The first big rally of 2023 will be put to the test next week when investors face a highly-anticipated inflation reading and fourth-quarter earnings from Wall Street's biggest banks.
Argentina and China have formalized the expansion of a currency swap deal, allowing the South American country to increase its depleted foreign currency reserves, the Argentine central bank said on Sunday. Argentina's government needs to rebuild reserves to cover trade costs and future debt repayments, and more reserves are a key objective of a major debt deal with the International Monetary Fund (IMF). President Alberto Fernandez announced the deal in November last year and said at the time it was worth $5 billion.
(Bloomberg) — Wall Street tech bulls are counting on the industry’s megacap stocks to move higher before long and jump start a rebound in the S&P 500.Most Read from BloombergGoldman to Cut About 3,200 Jobs This Week After Cost ReviewBrazil Capital Reels After Anti-Lula Rioters Storm CongressUkraine Latest: Zelenskiy Says Extra Troops Will Defend BakhmutPutin’s Energy Gambit Fizzles as Warm Winter Saves EuropeSouth Africa Has Its First Case of Most Transmissible Covid VariantThe hope is that the
Former U.S. Treasury Secretary Lawrence Summers said that he doesn't think the will return to an era of low interest rates once the spike in inflation is over.
Those laid off at the social media platform owned by Elon Musk include Nur Azhar Bin Ayob, a relatively recent hire as head of site integrity for the Asia-Pacific region, and Analuisa Dominguez, Twitter's senior director of revenue policy, Bloomberg reported. Workers on teams handling policy on misinformation, global appeals and state media on the platform were also eliminated, the report added.
With the shift away from pensions, workers are becoming more responsible for their own retirement needs. Unfortunately, many are falling short.
Some owners who used to break even on their condo investments now face a different reality
If you're looking to put away more money for retirement, you may have a goal in mind that you're trying to reach, such as saving $1 million. You may want to earn and save more than that, of course, but … Continue reading → The post How to Save $1 Million Dollars appeared first on SmartAsset Blog.
Bitcoin and Ether rose in Monday morning trading in Asia, rising with the rest of the top 10 non-stablecoin cryptocurrencies by market capitalization, with Cardano and BNB changing the most.
The market downturn has been brutal, but the good news is that the sell-off is starting to turn up some interesting investment opportunities. Three Motley Fool contributors recently picked Airbnb (NASDAQ: ABNB), Williams-Sonoma (NYSE: WSM), and Six Flags Entertainment (NYSE: SIX) as three undervalued stocks that are due for a rebound. Jennifer Saibil (Airbnb): Airbnb has quickly transitioned from an unprofitable growth stock to a profitable powerhouse travel leader.
The idea for raising salaries of top Illinois state government officials, which culminated this weekend with the House voting lawmakers an 18% pay hike, began with Gov. J.B. Pritzker. Pritzker said he wouldn't presume to tell the General Assembly what its members should be paid. “The Legislature is a coequal branch of government,” Pritzker said Saturday at a preinaugural community service event at Central Illinois Foodbank.
Last year proved to be one of the most challenging on record for investors. When we officially turned the page, the ageless Dow Jones Industrial Average (DJINDICES: ^DJI), widely followed S&P 500 (SNPINDEX: ^GSPC), and tech-dependent Nasdaq Composite (NASDAQINDEX: ^IXIC) respectively fell by 9%, 19%, and 33%. All three indexes spent at least some of 2022 entrenched in a bear market.
The tech-heavy Nasdaq Composite plunged 33% in 2022, coming off its worst year since 2008. After tech's heady days earlier in the pandemic, inflation reared its head for the first time since before the Great Financial Crisis, and the Federal Reserve raised interest rates at its fastest pace in decades. While some may be expecting a big bounce-back from the most beaten-down tech stocks (which have fallen the farthest), lots of uncertainty remains.
What you could do, though, is learn from the investing journeys of these three Motley Fool contributors. If these three had to build a stock portfolio from scratch starting with $15,000 right now, they would split the money across DigitalOcean (NYSE: DOCN), Veeva Systems (NYSE: VEEV), Shopify (NYSE: SHOP), as well as an S&P 500 index fund. Anthony Di Pizio (DigitalOcean): If I had to make a series of investments today, I'd start by identifying industries that are primed for growth over the next decade (and beyond).
While the healthcare industry may not seem at first glance like the most exciting place to invest your cash, it has proven to be one of the most resilient sectors for investing. Healthcare companies tend to supply the products and services that consumers need no matter what is happening with the market or the economy. If you are looking to add cash to more fantastic healthcare stocks in the month of January, here are two no-brainer buys that can enrich your portfolio over the long term.

source